220 related articles for article (PubMed ID: 19038232)
1. Regulation of genistein-induced differentiation in human acute myeloid leukaemia cells (HL60, NB4) Protein kinase modulation and reactive oxygen species generation.
Sánchez Y; Amrán D; de Blas E; Aller P
Biochem Pharmacol; 2009 Feb; 77(3):384-96. PubMed ID: 19038232
[TBL] [Abstract][Full Text] [Related]
2. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
Sánchez Y; Calle C; de Blas E; Aller P
Chem Biol Interact; 2009 Nov; 182(1):37-44. PubMed ID: 19720055
[TBL] [Abstract][Full Text] [Related]
3. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
4. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
5. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
Rosato RR; Almenara JA; Grant S
Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.
Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P
J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261
[TBL] [Abstract][Full Text] [Related]
7. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
[TBL] [Abstract][Full Text] [Related]
8. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation.
Su JC; Lin KL; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR
Life Sci; 2009 Sep; 85(13-14):505-16. PubMed ID: 19699753
[TBL] [Abstract][Full Text] [Related]
9. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-D-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways.
Estañ MC; Calviño E; de Blas E; Boyano-Adánez Mdel C; Mena ML; Gómez-Gómez M; Rial E; Aller P
Biochem Pharmacol; 2012 Dec; 84(12):1604-16. PubMed ID: 23041229
[TBL] [Abstract][Full Text] [Related]
11. Betuletol 3-methyl ether induces G(2)-M phase arrest and activates the sphingomyelin and MAPK pathways in human leukemia cells.
Rubio S; Quintana J; Eiroa JL; Triana J; Estévez F
Mol Carcinog; 2010 Jan; 49(1):32-43. PubMed ID: 19676104
[TBL] [Abstract][Full Text] [Related]
12. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
13. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
[TBL] [Abstract][Full Text] [Related]
14. The anti-leukaemic activity of novel synthetic naphthoquinones against acute myeloid leukaemia: induction of cell death via the triggering of multiple signalling pathways.
Hallak M; Win T; Shpilberg O; Bittner S; Granot Y; Levy I; Nathan I
Br J Haematol; 2009 Nov; 147(4):459-70. PubMed ID: 19747367
[TBL] [Abstract][Full Text] [Related]
15. MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia.
Barbarroja N; Siendones E; Torres LA; Luque MJ; Martinez JM; Dorado G; Velasco F; Torres A; López-Pedrera C
Br J Haematol; 2008 Jul; 142(1):27-35. PubMed ID: 18445086
[TBL] [Abstract][Full Text] [Related]
16. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells.
Matsumoto E; Hatanaka M; Bohgaki M; Maeda S
Kobe J Med Sci; 2006; 52(6):181-94. PubMed ID: 17329956
[TBL] [Abstract][Full Text] [Related]
17. Diallyl trisulfide-induced G(2)-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphosphorylation of Cdc 25 C.
Xiao D; Herman-Antosiewicz A; Antosiewicz J; Xiao H; Brisson M; Lazo JS; Singh SV
Oncogene; 2005 Sep; 24(41):6256-68. PubMed ID: 15940258
[TBL] [Abstract][Full Text] [Related]
18. Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle.
Cappelletti V; Fioravanti L; Miodini P; Di Fronzo G
J Cell Biochem; 2000 Sep; 79(4):594-600. PubMed ID: 10996850
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
[TBL] [Abstract][Full Text] [Related]
20. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis.
Yan W; Arai A; Aoki M; Ichijo H; Miura O
Biochem Biophys Res Commun; 2007 Apr; 355(4):1038-44. PubMed ID: 17331470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
